Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Sell
8,457
-22
-0.3% -$4.73K 0.28% 56
2026
Q1
$1.84M Sell
8,479
-137
-2% -$30.4K 0.27% 60
2025
Q4
$1.97M Sell
8,616
-731
-8% -$167K 0.28% 53
2025
Q3
$2.16M Sell
9,347
-335
-3% -$68.2K 0.32% 50
2025
Q2
$1.8M Sell
9,682
-235
-2% -$43.7K 0.28% 58
2025
Q1
$2.08M Sell
9,917
-200
-2% -$38.9K 0.35% 48
2024
Q4
$1.8M Buy
+10,117
New +$1.86M 0.3% 54

Other funds holding ABBV

Crews Bank & Trust's ABBV Position: Q2 2026 in Review

Crews Bank & Trust reduced its AbbVie (ABBV) stake by 0.26% in Q2 2026, selling an estimated $4.73K and leaving 8,457 shares worth $2.13M. The position accounts for 0.28% of the portfolio, ranked #56.

Crews Bank & Trust first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.16M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crews Bank & Trust held 8,457 shares of AbbVie worth $2.13M as of Q2 2026.
  • Crews Bank & Trust sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
  • AbbVie made up 0.28% of Crews Bank & Trust's portfolio in Q2 2026, its #56 holding.
  • Crews Bank & Trust first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Crews Bank & Trust's AbbVie position peaked at $2.16M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.